March 22, 2010 – An FDA committee voted unanimously in favor of approval with conditions of a new pacemaker that is safe for use in magnetic resonance imaging (MRI) systems. MRI procedures are not recommended in the United States for patients who currently have implanted pacemakers.

March 22, 2010 – A pivotal clinical trial recently began to gain U.S. approval for a defibrillator system that does not have any leads in or on the heart. Additionally, no imaging equipment is required for placement of the system, since all of the components are positioned using anatomical landmarks.

March 19, 2010 – An experimental factor Xa inhibitor given to patients with non-valvular atrial fibrillation (AF) or atrial flutter and at least one risk factor for stroke, reduced the incidence of major and clinically relevant non-major (CRNM) bleeds compared to dose-adjusted warfarin.

March 15, 2010 — Results from the PERSEUS clinical program demonstrate positive safety and efficacy outcomes in workhorse lesions for a new platinum chromium stent system.

March 18, 2010 — New data from two subanalyses of the Treating to New Targets (TNT) trial showed an increased dose of atorvastatin calcium (Lipitor), lowered cardiovascular events among high-risk patients with both coronary heart disease (CHD) and chronic kidney disease (CKD) who were obese or had metabolic syndrome.

March 17, 2010 – New Results from PLATO trial suggest ticagrelor (Brilinta) leads to lower mortality and no increased risk of bleeding when compared to clopidogrel (Plavix) in patients with acute coronary syndrome who undergo coronary artery bypass graft (CABG) surgery.

March 17, 2010 – A new agreement with Siemens Medical Solutions expands access to the wireless PressureWire Aeris fractional flow reserve (FFR) measurement technology. St. Jude Medical also announced several updates to its PressureWire platform this week at ACC 2010.

March 17, 2010 — When working on patients in a hybrid setting, it is critical the imaging system provides outstanding image quality, as well as the flexibility to reach ancillary equipment and the patient quickly and easily.

March 15, 2010 — Investigators reported the long-term follow-up of the largest randomized comparison between the two drug-eluting stents during the American College of Cardiology annual meeting this week in Atlanta.

March 16, 2010 — Lowering blood pressure to normal levels — below currently recommended levels — did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now